Safety Trial of Antimicrobial Therapy and Precision Radiation Therapy in Patients With Oligoprogressive Non-small Cell Lung Cancer

Abroad (travel likely)RecruitingPHASE1

Conditions

Early Stage Non-Small Cell Lung Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

University of Pennsylvania, Philadelphia, Pennsylvania, United States
Contact: Study coordinator (Ching Lai) · ching.lai@pennmedicine.upenn.edu · 267-250-9244
Contact: Study coordinator (RadOnc Clinical Research Unit) · radonccru@pennmedicine.upenn.edu
Contact: Principal Investigator (Steven Feigenberg, MD)

Study leads

Steven Feigenberg, MD
Principal Investigator
University of Pennsylvania

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Near-Infrared Fluorescence Guided Robotic Pulmonary Segmentectomy for Early Stage Lung Cancer

Non-small Cell Lung Cancer

Abroad (travel likely)RecruitingPHASE1

Hamilton, Canada

Study Comparing Two Different Schedules of Radiation for Early-stage Lung Cancer

Lung Cancer

Abroad (travel likely)Recruiting

Rochester, United States

Neoadjuvant Dupilumab and Cemiplimab in Patients With Early-stage Resectable NSCLC

Non-Small Cell Lung Cancer

Abroad (travel likely)RecruitingPHASE1, PHASE2

New York, United States

Multi-omics Study of Early-stage Lung Cancer With Distinct Phenotypes

Lung Cancer Associated With Cystic Airspaces · Multiple Primary Lung Cancers · Non-Small Cell Lung Cancer

Abroad (travel likely)Recruiting

Changsha, China